CD8A and neoplasm: An evaluation of the immune response to the virotherapy by LIVP-FlaB-RFP indicated significantly enhanced recruitment of the macrophages and CD8+ lymphocytes to the tumor site compared to the group treated by LIVP-RFP or the control.